Cholesterol biosynthesis in normocholesterolemic patients after cholesterol removal by plasmapheresis

Journal of Clinical Apheresis

Volumn 12, Issue 3, 1997, Pages 110-115

  Feillet, C ^a   Cristol, J P ^a   Michel, F ^a   Kanouni, T ^a   Navarro, R ^a   Navarro, M ^a   Monnier, L ^a   Descomps, B ^a  

^a LAPEYRONIE HOSPITAL   (France)

Author keywords

Cholesterol synthesis; Lathosterol; LDL apheresis; Mevalonic acid; Plasmapheresis

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LATHOSTEROL; LIPID; LOW DENSITY LIPOPROTEIN; MEVALONIC ACID; TRIACYLGLYCEROL;

ADULT; ARTICLE; CASE REPORT; CHOLESTEROL SYNTHESIS; CRYOGLOBULINEMIA; FEMALE; HUMAN; HYPOCHOLESTEROLEMIA; MALE; MYASTHENIA; PLASMAPHERESIS;

CHOLESTEROL; FEMALE; HUMANS; MALE; MEVALONIC ACID; MIDDLE AGED; PLASMAPHERESIS;

EID: 0030830372     PISSN: 07332459     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-1101(1997)12:3<110::AID-JCA2>3.0.CO;2-D     Document Type: Article

References (19)

1. Pfolh M, Naoumova RP, Class C, Knisel W, Jakober B, Risler T, Thompson G: Acute and chronic effect on cholesterol biosynthesis of LDL-apheresis with or without concomitant HMGCoA reductase inhibitor therapy. J Lipid Res 35:1946-1955, 1994.
2. Björkem I, Miettinen TA, Reihner E, Ewerth S, Angelin B, Einarsson K: Correlation between serum levels of some cholesterol precursors and activity of HMGCoA reductase in human liver. J Lipid Res 28:1137-1143, 1987.
3. Kempen HJM, Glatz JFC, Gevers Leuven JA, Van der Voort HA, Katan MB: Serum lathosterol concentration is an indicator of whole body cholesterol synthesis in humans. J Lipid Res 29:1149-1155, 1988.
4. Wolthers BG, Walrecht HT, Van Der Molen JC, Nagel GT, Van Der Mal JJ, Winjnandts PN: Use of determination of 7-lathosterol (5-cholesten-7-en-3-ol) and other cholesterol precursors in serum in the study and treatment of disturbances of sterol metabolism, particularly cerebrotendinous xanthomatosis. J Lipid Res 32:603-612, 1991.
5. Popjak G, Boehm G, Parker TS, Edmond J, Edward PA, Folgelman AM: Determination of mevalonate in blood plasma in man and in rat. Mevalonate "tolerance" tests in man. J Lipid Res 20:716-728, 1979.
6. Parker TS, McNamara DJ, Brown C, Garrigan O, Kolb R, Batuni H, Ahrens EH: Mevalonic acid in human plasma: relationship of concentration and circadian rhythm to cholesterol synthesis rates in man. Proc Natl Acad Sci USA 79:3037-3041, 1982.
7. Assman G, Lewis B, Mancini M, Paoletti R, Schettler G: Strategies for the prevention of coronary artery disease: a policy statement of the European Atherosclerosis Society. Eur J Cardiol 8: 77-85, 1987.
8. Jones PJH, Shoeller DA: Evidence for a diurnal periodicity in human cholesterol synthesis. J Lipid Res 32:667-673, 1991.
9. Burstein M, Morfin R: Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res 11:583-595, 1970.
10. Fievet-Desreumaux C, Dedonder-Decoopman E, Fruchart JC, Dewailly P, Sezille G: Immunochemical determination of human apolipoprotein B by laser nephelometry. Clin Chem Acta 95:405-408, 1979.
11. Feillet C, Monnier LH, Barjon JN, Perrin M, Descomps B, Crastes de Faulet A: Influence of short-term stimulatory effect of insulin on cholesterol synthesis in newly insulin-treated diabetic patients. Metabolism 43:1233-1240, 1994.
12. Koivisto VI, Miettinen TA: Increased amounts of cholesterol precursors in lipoproteins after ileal exclusion. Lipids 23:993-996, 1988.
13. Hagenfeldt L, Hellström K: Blood concentration and turnover of circulating mevalonate in the rat. Life Sci 11:669-676, 1972.
14. Tint GS, Salen G: Evidence for the early conversion of the 24,25 double bond in the conversion of lanosterol to cholesterol in cerebrotendinous xanthomatosis. Metabolism 26:721-729, 1977.
15. De Cuyper I, Wolthers BG, Van Doormaal JJ, Wijnandts PN: Determination of changes in serum lathosterol during treatment with simvastatin to evaluate the role of lathosterol as a parameter for whole body cholesterol synthesis. Clin China Acta 219:123-130, 1993.
16. Soutar AK, Myant NB, Thompson GR: Metabolism of apolipoprotein B-containing lipoproteins in familial hypercholesterolemia. Effects of plasma exchange. Atherosclerosis 32:315-325, 1979.
17. Arends J, Bier DM, Schaefer G, Armstrong VW, Thiery J, Seidel D, Schauer P: No evidence for feedback inhibition of hepatic apolipoprotein B (apoB) production after extracorporeal low density lipoprotein precipitation as determined by [1-13C]leucine infusion in normal volunteers. Eur J Clin Invest 23:602-614, 1993.
18. Ciavarella D, Wuest D, Strauss RG, Gilcher RO, Kasprisin DO, Kiprov DD, Klein HG, McLeod BC: Management of neurologic disorders. J Clin Apheresis 8:242-257, 1993.
19. Gilcher RO, Strauss RG, Ciavarella D, Kasprisin DO, Kiprov DD, Klein HG, McLeod BC: Management of renal disorders. J Clin Apheresis 8:258-269, 1993.